Pharmaceutical manufacturing

Dr. Robin Armstrong puts on his face shield while demonstrating his full personal protective equipment outside the entrance to The Resort at Texas City nursing home, where he is the medical director, Tuesday, April 7, 2020, in Texas City, Texas. Armstrong is treating nearly 30 residents of the nursing home with the anti-malaria drug hydroxychloroquine, which is unproven against COVID-19 even as President Donald Trump heavily promotes it as a possible treatment. Armstrong said Trump's championing of the drug is giving doctors more access to try it on coronavirus patients. More than 80 residents and workers have tested positive for coronavirus at the nursing home. (AP Photo/David J. Phillip)
1010 WINS Newsroom
April 07, 2020 - 6:40 pm
AUSTIN, Texas (AP) — When a coronavirus outbreak hit a Texas nursing home, Dr. Robin Armstrong reached for an uproven treatment: the anti-malaria drug hydroxychloroquine. First, he needed to find a supply. But at a moment when President Donald Trump is heavily promoting the drug, Armstrong is no...
Read More
In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
1010 WINS Newsroom
April 06, 2020 - 9:12 am
The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit. When they offered him a chance to help test...
Read More
iStock
1010 WINS Newsroom
April 06, 2020 - 8:51 am
A second U.S. company is poised to begin a small safety test of a vaccine against the new coronavirus. Inovio Pharmaceuticals said Monday that it has Food and Drug Administration permission for the study in 40 healthy volunteers in Philadelphia and Kansas City, Missouri. The study is a first step...
Read More
FILE - This Sept. 30, 2019 file photo shows a box of Zantac tablets at a pharmacy in Miami Beach, Fla. On Wednesday, April 1, 2020, U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The warning applies to all prescription and over-the-counter versions of ranitidine, best known by the brand name Zantac. (AP Photo/Wilfredo Lee, File)
1010 WINS Newsroom
April 01, 2020 - 1:19 pm
WASHINGTON (AP) — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The move from the Food and Drug Administration Wednesday...
Read More
FILE - In this Nov. 28, 2018, file photo, the Department of Justice seal is seen in Washington, D.C. An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, in an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas on Sunday, March 22, 2020, ordered the takedown of a website the U.S. Department of Justice accused of stealing credit card information while offering fake coronavirus vaccine kits. (AP Photo/Jose Luis Magana, File)
1010 WINS Newsroom
March 26, 2020 - 6:31 pm
BOSTON (AP) — An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas ordered the takedown...
Read More
In this photo released by Saudi Press Agency, SPA, Saudi King Salman, chairs a video call of world leaders from the Group of 20 and other international bodies and organizations, from his office in Riyadh, Saudi Arabia, Thursday, March 26, 2020. The meeting is aimed at coordinating the global response to the fast-spreading coronavirus, which has shuttered businesses and forced well over a quarter of the world's population into home isolation. (Saudi Press Agency via AP)
1010 WINS Newsroom
March 26, 2020 - 2:25 pm
DUBAI, United Arab Emirates (AP) — The head of the United Nations told leaders of the world’s 20 major industrialized nations during an emergency virtual summit Thursday that "we are at war with a virus – and not winning it” despite dramatic measures by countries to seal their borders, shutter...
Read More
FILE - In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment. (AP Photo/Eric Risberg, File)
1010 WINS Newsroom
March 25, 2020 - 3:55 pm
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S. regulators to revoke the so-...
Read More
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
1010 WINS Newsroom
March 24, 2020 - 9:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. On Tuesday, March 24, 2020, the U.S. Food and Drug Administration warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions. (AP Photo/Rich Pedroncelli, File)
1010 WINS Newsroom
March 24, 2020 - 6:21 pm
U.S. regulators on Tuesday warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions. The Food and Drug Administration issued the warning after drugmakers Pfizer and Mylan told medical providers that the problems could cause death or serious...
Read More
President Donald Trump speaks during a meeting with tourism industry executives about the coronavirus, in the Cabinet Room of the White House, Tuesday, March 17, 2020, in Washington. (AP Photo/Evan Vucci)
1010 WINS Newsroom
March 18, 2020 - 8:47 am
WASHINGTON (AP) — President Donald Trump has sent lawmakers a $46 billion emergency funding request to help the government fight the coronavirus and to reverse cuts proposed just last month to the Centers for Disease Control, the front-line agency in fighting the battle. The huge request, delivered...
Read More

Pages